Publication | Open Access

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Carboplatin/paclitaxel Versus PlaceboBreast OncologyRecurrent/metastatic Breast CancerMedicinePharmacologyPathologyPhase Ii StudyBreast CancerCancer TreatmentOncologyRadiation OncologyMolecular Oncology